FDAApproved

What we know and don’t know about the FDA-approved postpartum depression pill

by
What we know and don't know about the FDA-approved postpartum depression pill

Postpartum depression affects up to 1 in 7 women. The first pill to treat it is expected to become available later this year, after the FDA approved it on Friday. Getty Images hide caption toggle caption Getty Images Postpartum depression affects up to 1 in 7 women. The first pill to treat it is expected … Read more

Viatris Announces Launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva

by
Viatris Announces Launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva

Launch demonstrates companies’ commitment to bringing complex generic medicines to the market to help increase patient access PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca’s Symbicort … Read more